Hb Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Hb Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$60.67 - $89.12 $47,989 - $70,493	791 Added 23.9%	4,101 $279,000
Q4 2023 Jan 16, 2024	BUY	$38.62 - $72.18 $127,832 - $238,915	3,310 New	3,310 $207,000
Q3 2022 Oct 19, 2022	SELL	$61.1 - $83.78 $6,110 - $8,378	-100 Reduced 2.2%	4,452 $291,000
Q2 2022 Jul 15, 2022	BUY	$43.23 - $73.83 $32,422 - $55,372	750 Added 19.73%	4,552 $277,000
Q4 2021 Feb 15, 2022	BUY	$70.09 - $111.29 $266,482 - $423,124	3,802 New	3,802 $288,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hb Wealth Management, LLC with notifications on news.